<DOC>
	<DOCNO>NCT00100399</DOCNO>
	<brief_summary>The purpose study test immune response cause investigational Fluarix vaccine healthy people age 18-64 year U.S.A. Up 1050 volunteer 4 center receive Fluarix Placebo ( saline ) , response compare . Subjects place age 2 group ( 18 49 year old 50 64 year old ) , randomly assign receive dose Fluarix Placebo injection muscle . There 2 phase study : ( 1 ) active study phase ( 2 visit ) subject ; ( 2 ) cross-over phase , subject enrol placebo group accept receive Fluarix . Blood sample obtain order measure immune response vaccine . On day vaccination , volunteer receive diary card record information symptom experience next 3 day . Subject participation either group 2 month .</brief_summary>
	<brief_title>Fluarix Immunogenicity Safety Trial</brief_title>
	<detailed_description>This study randomize , double-blinded , placebo control Phase III study evaluate immunogenicity safety GSK Bio influenza vaccine ( Fluarix ) administer intramuscularly healthy adult age 18 64 year . Vaccination currently effective mean control influenza prevent complication mortality person risk . Following vaccination , seroprotective antibody titer achieve high proportion vaccinate subject . GlaxoSmithKline Biologicals ( GSK Bio ) marketing inactivate influenza split vaccine ( Fluarix® ) since 1992 . More 126 million dos distribute vaccine register 78 country . It well tolerate proven highly immunogenic inject intramuscular route .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>1 . A male female age between1864 year time vaccination . 2 . Subjects investigator believe comply requirement protocol ( e.g. , return followup visit completion diary card ) enrol study . 3 . Written inform consent obtain subject . 4 . Free obvious health problem establish medical history clinical examination enter study . 5 . Female subject must nonchildbearing potential , i.e . either surgically sterilize one year postmenopausal . If subject childbearing potential , must abstinent use adequate contraceptive precaution ( e.g . intrauterine contraceptive device ; oral contraceptive equivalent hormonal contraception , e.g . progestogenonly implantable , cutaneous hormonal patch injectable contraceptive , diaphragm condom combination contraceptive jelly , cream foam ) 30 day prior vaccination . She must also negative pregnancy test study entry must agree continue precaution two month completion vaccination . 1 . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede administration study vaccine , plan use study period . 2 . Has receive license vaccine within 2 week ( inactivated vaccine ) 4 week ( live vaccine ) prior enrollment study . 3 . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior administration study vaccine . ( For corticosteroid , mean prednisone , equivalent , &gt; = 0.5 mg/kg/day . ) 4 . Any medically diagnose suspect immunodeficient condition base medical history physical examination ( laboratory testing require ) . 5 . Administration immunoglobulins and/or blood product within three month precede administration study vaccine study . 6 . History hypersensitivity previous dose influenza vaccine . 7 . History allergy reaction likely exacerbate component vaccine include egg , chicken protein , formaldehyde , gentamicin sulfate sodium deoxycholate . 8 . Previous vaccination influenza ( 20042005 influenza vaccine ) within 9 month prior enrollment . 9 . Acute disease time enrollment . ( Acute disease define presence moderate severe illness without fever . All vaccine administer person minor illness diarrhea , mild upper respiratory infection without lowgrade febrile illness , i.e . Oral temperature &lt; 37.5°C ( 99.5°F ) / Axillary temperature &lt; 37.5°C ( 99.5°F ) ) . 10 . Acute clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . 11 . Major congenital defect serious chronic illness . 12 . History neurologic disorder , include history Guillain Barré syndrome 13 . History seizure , exception single febrile seizure childhood . 14 . Pregnant lactate female . 15 . Female plan become pregnant planning discontinue contraceptive precaution within 2 month enrollment study . 16 . Has underlie medical condition influenza vaccination recommend : chronic heart lung condition , include asthma ; metabolic disease ; kidney disease ; blood disorder ( sickle cell anemia ) ; weaken immune system , include HIV/AIDS . 17 . 18 year age chronic aspirin therapy 18 . Residents nurse home long term care facility . 19 . Health care worker involve direct patient care . 20 . Outofhome caregiver household contact child &lt; 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>influenza , flu , Fluarix , vaccine , GSK , immunogenicity</keyword>
</DOC>